Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics. | Front Immunol | 2023 | 38299154 | PubTator, text mining | PubMed |
| Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation. | Front Immunol | 2023 | 38268918 | PubTator, text mining | PubMed |
| Destabilizing the genome as a therapeutic strategy to enhance response to immune checkpoint blockade: a systematic review of clinical trials evidence from solid and hematological tumors. | Front Pharmacol | 2023 | 38264532 | PubTator, text mining | PubMed |
| The role of natural killer T cells in liver transplantation. | Front Cell Dev Biol | 2023 | 38250325 | PubTator, text mining | PubMed |
| Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy. | Curr Issues Mol Biol | 2023 | 38248313 | PubTator, text mining | PubMed |
| Immunomodulatory effects of exercise in cancer prevention and adjuvant therapy: a narrative review. | Front Physiol | 2023 | 38239881 | PubTator, text mining | PubMed |
| Current status and future perspective of natural killer cell therapy for cancer. | Med Rev (2021) | 2023 | 38235405 | PubTator, text mining | PubMed |
| Optimizing the cryopreservation and post-thaw recovery of natural killer cells is critical for the success of off-the-shelf platforms. | Front Immunol | 2023 | 38193082 | PubTator, text mining | PubMed |
| IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide. | Front Immunol | 2023 | 38162653 | PubTator, text mining | PubMed |
| Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs. | Sci Rep | 2023 | 38155275 | PubTator, text mining | PubMed |
| Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity. | Front Immunol | 2023 | 38143742 | PubTator, text mining | PubMed |
| The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy. | Int J Mol Sci | 2023 | 38139373 | PubTator, text mining | PubMed |
Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 Glioma. | Biomedicines | 2023 | 38137456 | PubTator, text mining | PubMed |
| Unlocking Glioblastoma Secrets: Natural Killer Cell Therapy against Cancer Stem Cells. | Cancers (Basel) | 2023 | 38136381 | PubTator, text mining | PubMed |
| Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections. | Cancers (Basel) | 2023 | 38136285 | PubTator, text mining | PubMed |
| g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral blood. | Oncoimmunology | 2023 | 38126036 | PubTator, text mining | PubMed |
| Immune and oxidative stress disorder in ovulation-dysfunction women revealed by single-cell transcriptome. | Front Immunol | 2023 | 38116006 | PubTator, text mining | PubMed |
| Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy. | PLoS One | 2023 | 38096229 | PubTator, text mining | PubMed |
| Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis. | Cell | 2023 | 38091993 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=10